Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract outlines the continuation of the Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D) Consortium under the NIH, focusing on advancing research into cardiovascular disease (CVD) in individuals with type 1 diabetes (T1D). Cardiovascular complications remain the leading cause of death among people with T1D, and despite management of traditional risk factors such as blood glucose, blood pressure, and cholesterol, significant residual cardiovascular risk persists. The contract emphasizes the need to better understand the mechanisms behind atherosclerosis, cardiomyopathy, endothelial dysfunction, and cardiac autonomic neuropathy specific to T1D, as well as the fact that no targeted therapies currently exist to prevent or treat these cardiovascular complications. This solicitation, issued by the National Institutes of Health as part of the Special Diabetes Program, supports collaborative and interdisciplinary research efforts to deepen the understanding of CVD development unique to T1D by continuing the work of the CaRe-T1D consortium. The award mechanism is a U01 cooperative agreement for research without clinical trials, encouraging innovative research collaborations that aim to reduce morbidity and mortality associated with cardiovascular issues in T1D. The application deadline is March 10, 2027, and interested parties can direct inquiries to the NIH contact provided.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
